REBETRON R 200mg / 3MUI / 0.5ml capsules + injection solution medication leaflet

J05AB54 • ribavirin + interferon alfa 2B • Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors

The combination of ribavirin and interferon alfa-2B is used for the treatment of chronic hepatitis C. Ribavirin inhibits viral replication, while interferon alfa-2B enhances the body's immune response against the virus.

The medication is administered orally (ribavirin) and by injection (interferon alfa-2B), as directed by a doctor. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the therapy's effectiveness and side effects.

Patients should be aware of potential side effects, such as anemia, fatigue, flu-like symptoms, or depression. It is important to inform the doctor of any unusual symptoms.

Common side effects include anemia, fatigue, flu-like symptoms, and skin irritation. In rare cases, severe reactions such as severe depression or liver dysfunction may occur. Patients should be informed of these risks before use.